Tautomers of styrylquinoline derivatives containing a methoxy substituent: Computation of their population in aqueous solution and their interaction with RSV integrase catalytic core

Acta Biochimica Polonica

Volumn 47, Issue 1, 2000, Pages 11-22

  Ouali, Mohammed ^a   Laboulais, Cyril ^a   Leb, Hervé ^a   Gill, David ^a   Xhuvani, Emil ^a   Zouhiri, Fatima ^b   Desmaële, Didier ^b   D'Angelo, Jean ^b   Auclair, Christian ^a   Mouscadet, Jean François ^a   Le Bret, Marc ^a  

^a CNRS   (France)

^b UNIVERSITÉ PARIS SUD   (France)

Author keywords

Docking; Integrase inhibitors; Solvent effects; Styrylquinoline

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1; RICE STRIPE VIRUS; ROUS SARCOMA VIRUS;

INTEGRASE; QUINONE DERIVATIVE; WATER;

ARTICLE; AVIAN SARCOMA VIRUS; CHEMISTRY; ENZYME ACTIVE SITE; ENZYMOLOGY; METABOLISM; SOLUTION AND SOLUBILITY; SPECTROFLUOROMETRY; STEREOISOMERISM;

AVIAN SARCOMA VIRUSES; CATALYTIC DOMAIN; INTEGRASES; QUINONES; SOLUTIONS; SPECTROMETRY, FLUORESCENCE; STEREOISOMERISM; WATER;

EID: 0033643688     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2000_4058     Document Type: Article

References (42)

1. Aqvist, J. (1990) Ion-water interaction potentials derived from free energy perturbation simulations. J. Phys. Chem. 94, 8021-8024.
2. Bardez, E., Devol, I., Larrey, B. & Valeur, B. (1997) Excited-state processes in 8-hydroxyquinoline: photoinduced tautomerization and solvation effects. J. Phys. Chem. B 101, 7786-7793.
3. Barone, V., Cossi, M. & Tomasi, J. (1997) A new definition of cavities for the computation of solvation free energies by the polarizable continuum model. J. Chem. Phys. 107, 3210-3221.
4. Barone, V. & Cossi, M. (1998) Quantum calculation of molecular energies and energy gradi-ents in solution by a conductor solvent model. J. Phys. Chem. A 102, 1995-2001.
5. Beese, L.S. & Steitz, T.A. (1991) Structural basis for the 3′-5′ exonuclease activity of Escherichia coli DNA polymerase I: A two metal ion mechanism. EMBO J. 10, 25-33.
6. Besler, B.H., Merz, K.M. & Kollman, P.A. (1990) Atomic charges derived from semiempirical methods. J. Comp. Chem. 11, 431-439.
7. Branch, G.E.K. & Yabroff, D.L. (1934) The anomalous strength of salicylic acid. J. Am. Chem. Soc. 56, 2568-2570.
8. Brown, P.O. (1990) Integration of retroviral DNA. Curr. Top. Microbiol. Immunol. 157, 19-48.
9. Bujacz, G., Jaskólski, M., Alexandratos, J., Wlodawer, A., Merkel, G., Katz, R.A. & Skalka, A.M. (1995) High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J. Mol. Biol. 253, 333-346.
10. Bushman, F.D. & Craigie, R. (1991) Activities of human immunodeficiency virus (HIV) integration protein in vitro: Specific cleavage and integration of HIV DNA. Proc. Natl. Acad. Sci. U.S.A. 88, 1339-1343.
11. Chow, S.A., Vincent, K.A., Ellison, V. & Brown, P.O. (1992) Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science 255, 723-726.
12. Cornell, W.D., Cieplak, P., Bayly, C.I., Goulg, I.R., Merz, K.M., Jr., Ferguson, D.M., Spellmeyer, D.C., Fox, T., Caldwell, J.W. & Kollman, P.A. (1995) A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 117, 5179-5197.
13. Cowan, J.A. (1998) Metal activation of enzymes in nucleic acid biochemistry. Chem. Rev. 98, 1067-1087.
14. De Clercq, E. (1995) Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections. J. Med. Chem. 38, 2491-2517.
15. Dunn, G.E. & McDonald, R.S. (1969) Infrared spectra of aqueous sodium benzoates and salicylates in the carboxyl-stretching region: Chelation in aqueous sodium salicylates. Can. J. Chem. 47, 4577-4588.
16. Dyda, F., Hickman, A.B., Jenkins, T., Engelman, A., Craigie, R. & Davies, D. (1994) Crystal structure of the catalytic domain of HIV-1 integrase: Similarity to other polynucleotidyl transferases. Science 266, 1981-1986.
17. Engelman, A., Mizuuchi, K. & Craigie, R. (1991) HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer. Cell 67, 1211-1221.
18. Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Zakrzewski, V.G., Montgomery, J.A., Stratmann, R.E., Burant, J.C., Dapprich, S., Millam, J.M., Daniels, A.D., Kudin, K.N., Strain, M.C., Farkas, O., Tomasi, J., Barone, V., Cossi, M., Cammi, R., Mennucci, B., Pomelli, C., Adamo, C., Clifford, S., Ochterski, J., Petersson, G.A., Ayala, P.Y., Cui, Q., Morokuma, K., Malick, D.K., Rabuck, A.D., Raghavachari, K., Foresman, J.B., Cioslowski, J., Ortiz, J.V., Stefanov, B.B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, I., Gomperts, R., Martin, R.L., Fox, D.J., Keith, T., Al-Laham, M.A., Peng, C.Y., Nanayakkara, A., Gonzalez, C., Challacombe, M., Gill, P.M. W., Johnson, B.G., Chen, W., Wong, M.W., Andres, J.L., Gonzalez, C., Head-Gordon, M., Replogle, E.S. & Pople, J.A. (1998) Gaussian 98, Revision A.6, Gaussian, Inc., Pittsburgh PA.
19. Furtado, M., Callaway, D., Phair, J., Kunstman, K., Stanton, J., Macken, C., Perelson, A. & Wolinsky, S. (1999) Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N. Engl. J. Med. 340, 1614-1622.
20. Gabb, H., Jackson, R. & Sternberg, M. (1997) Modelling protein docking using shape complementarity, electrostatics and biochemical information. J. Mol. Biol. 272, 106-120.
21. Goldgur, Y., Dyda, F., Hickman, A., Jenkins, T., Craigie, R. & Davies, D. (1998) Three new structures of the core domain of HIV-1 integrase: An active site that binds magnesium. Proc. Natl. Acad. Sci. U.S.A. 95, 9150-9154.
22. Goldgur, Y., Craigie, R., Cohen, G., Fujiwara, T., Yoshinaga, T., Fujishita, T., Sugimoto, H., Endo, T., Murai, H. & Davies, D. (1999) Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design. Proc. Natl. Acad. Sci. U.S.A. 96, 13040-13043.
23. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M. & Markowitz, M. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
24. Katz, R.A. & Skalka, A.M. (1994) The retroviral enzymes. Annu. Rev. Biochem. 63, 133-173.
25. Katchalski-Katzir, E., Shariv, I., Eisenstein, M., Friesem, A.A., Aflalo, C. & Vakser, I.A. (1992) Molecular surface recognition: Determination of geometric fit between proteins and their ligands by correlation techniques. Proc. Natl. Acad. Sci. U.S.A. 89, 2195-2199.
26. Klamt, A. & Schürmann, G. (1993) COSMO: A new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient J. Chem. Soc. Perkin Trans. 2, 799-805.
27. Lahmani, F. & Zehnacker-Rentien, A. (1997) Effect of substitution on the photoinduced intramolecular proton transfer in salicylic acid. J. Phys. Chem. A 101, 6141-6147.
28. LaFemina, R.L., Schneider, C.L., Robbins, H.L., Callahan, P.L., Legrow, K., Roth, E., Schleif, W.A. & Emini, E.A. (1992) Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J. Virol. 66, 7414-7419.
29. Lange (1967) Handbook of Chemistry (Dean, J.A., ed.) 15th edition, Mc Graw-Hill Inc.)
30. Lavery, R., Sklenar, H., Zakrzewska, K. & Pullman, B. (1986) The flexibility of the nucleic acids: (II). The calculation of internal energy and applications to mononucleotide repeat DNA. J. Biomol. Struct. Dyn. 3, 989-1014.
31. Le Bret, M., Gabarro-Arpa, J., Gilbert, J.C. & Lemaréchal, C. (1991) MORCAD, an object-oriented molecular modelling package running on IBM RS/6000 and SGI 4Dxxx workstations. J. Chim. Phys. 88, 2489-2496.
32. Maignan, S., Guilloteau, J.P., Zhou-Liu, Q., Clément-Mella, C. & Mikol, V. (1998) Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: High level of similarity of the active site with other viral integrases. J. Mol. Biol. 282, 359-368.
33. Mekouar, K., Mouscadet, J.F., Desmaële, D., Subra, F., Leh, H., Savouré, D., Auclair, C. & d'Angelo, J. (1998) Styrylquinoline derivatives: A new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells. J. Med. Chem. 41, 2846-2857.
34. Ouali, M., Laboulais, C., Leh, H., Gill, D., Desmaële, D., Mekouar, K., Zouhiri, F., d'Angelo, J., Auclair, C., Mouscadet, J.F. & Le Bret, M. (2000) Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives. J. Med. Chem. (in press).
35. Pommier, Y. & Neamati, N. (1999) Inhibitors of human immunodeficiency virus integrase. Adv. Virus Res. 52, 427-458.
36. Rega, N., Cossi, M. & Barone, V. (1999) Improving performance of polarizable continuum model for study of large molecules in solution. J. Comput. Chem. 20, 1186-1198.
37. Rogers, N. & Sternberg, M. (1984) Electrostatic interactions in globular proteins. Different dielectric models applied to the packing of alpha-helices. J. Mol. Biol. 174, 527-542.
38. Shoichet, B.K. (1996) Docking ligands to proteins; in Protein Structure Prediction (Sternberg, M.J., ed.) The Practical Approach Series (Rickwood, D. & Hames, B., eds.) chapter 11, pp. 263-290.
39. Sobolewski, A. & Domcke, W. (1998) Ab initio study of excited state intramolecular proton dislocation in salicylic acid. Chem. Physics 232, 257-265.
40. Waldeck, D.H. (1991) Photoisomerisation dynamics of stilbene. Chem. Rev. 91, 415-436.
41. Zhang, L., Ramratnam, B., Tenner-Racz, K., He, Y., Vesanen, M., Lewin, S., Talal, A., Racz, P., Perelson, A., Korber, B., Markowitz, M. & Ho, D. (1999) Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N. Engl. J. Med. 340, 1605-1613.
42. Zouhiri, F., Mouscadet, J.F., Mekouar, Kh., Desmaele, D., Savouré, D., Leh, H., Subra, F., Le Bret, M., Auclair, C. & d'Angelo, J. (2000) Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1-integrase and replication of HIV-1 in cell culture. J. Med. Chem. (in press).